UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview

Therapeutic delivery, 2014-06, Vol.5 (6), p.709-733

2014

Volltextzugriff (PDF)

New Exhalation Delivery Systems (EDS) Enhance Topical Steroid Delivery In Chronic Rhinosinusitis With Nasal Polyps

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB65-AB65

2017

Volltextzugriff (PDF)

NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis

Journal of allergy and clinical immunology, 2019-01, Vol.143 (1), p.126-134.e5

2019

Volltextzugriff (PDF)

EXHANCE-3: A Phase 3, Three-Month Study of Safety and Efficacy of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) in Patients with Chronic Rhinosinusitis with (CRSwNP) and without Nasal Polyps (CRSsNP)

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB66-AB66

2017

Volltextzugriff (PDF)

NAVIGATE I: A Randomized Double-Blind Trial of a Fluticasone Propionate Exhalation Delivery System (FLU-EDS) for Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB66-AB66

2017

Volltextzugriff (PDF)

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps

American journal of rhinology & allergy, 2019-01, Vol.33 (1), p.69-82

2019

Volltextzugriff (PDF)

Looking to the future of nasal drug delivery - an interview with Per Gisle Djupesland

Therapeutic delivery, 2018-02, Vol.9 (3), p.163-168

Djupesland, Per G

2018

Volltextzugriff (PDF)

Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives

Therapeutic delivery, 2018-07, Vol.9 (7), p.515-525

2018

Volltextzugriff (PDF)

Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts

Therapeutic delivery, 2020-08, Vol.11 (8), p.485-495

2020

Volltextzugriff (PDF)

Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial

Psychoneuroendocrinology, 2016-07, Vol.69, p.180-188

2016

Volltextzugriff (PDF)

Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men

Hormones and behavior, 2018-06, Vol.102, p.85-92

2018

Volltextzugriff (PDF)

Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study

Neuropsychopharmacology (New York, N.Y.), 2019-01, Vol.44 (2), p.306-313

2019

Volltextzugriff (PDF)

Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder

Headache, 2013-09, Vol.53 (8), p.1323-1333

2013

Volltextzugriff (PDF)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Volltextzugriff (PDF)

Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI)

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB274-AB274

2018

Volltextzugriff (PDF)

Accessing the Brain: The Nose may Know the Way

Journal of cerebral blood flow and metabolism, 2013-05, Vol.33 (5), p.793-794

2013

Volltextzugriff (PDF)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Volltextzugriff (PDF)

EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

International forum of allergy & rhinology, 2018-08, Vol.8 (8), p.869-876

2018

Volltextzugriff (PDF)

EDS-FLU performs differently than other nasal corticosteroids

Journal of allergy and clinical immunology, 2019-07, Vol.144 (1), p.349-349

2019

Volltextzugriff (PDF)

Evidence is Limited for the Efficacy and Safety of Corticosteroid Irrigation in Chronic Rhinosinusitis (CRS)

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB282-AB282

2019

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Headache, 2015-01, Vol.55 (1), p.88-100

2015

Volltextzugriff (PDF)

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Health-Related Quality of Life (HRQoL) in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from NAVIGATE II

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB166-AB166

2018

Volltextzugriff (PDF)

EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps

International forum of allergy & rhinology, 2022-06, Vol.12 (6), p.893-895

2022

Volltextzugriff (PDF)

Letter to the Editor: Incorrect conclusions regarding deposition of conventional mometasone furoate (MF) nasal spray

Allergy and asthma proceedings, 2015-09, Vol.36 (5), p.e104-104

2015

Volltextzugriff (PDF)

Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device

Journal of pharmacy and pharmacology, 2009-09, Vol.61 (9), p.1219-1228

2009

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview

New Exhalation Delivery Systems (EDS) Enhance Topical Steroid Delivery In Chronic Rhinosinusitis With Nasal Polyps

NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis

EXHANCE-3: A Phase 3, Three-Month Study of Safety and Efficacy of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) in Patients with Chronic Rhinosinusitis with (CRSwNP) and without Nasal Polyps (CRSsNP)

NAVIGATE I: A Randomized Double-Blind Trial of a Fluticasone Propionate Exhalation Delivery System (FLU-EDS) for Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps

Looking to the future of nasal drug delivery - an interview with Per Gisle Djupesland

Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives

Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts

Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial

Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men

Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study

Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI)

Accessing the Brain: The Nose may Know the Way

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

EDS-FLU performs differently than other nasal corticosteroids

Evidence is Limited for the Efficacy and Safety of Corticosteroid Irrigation in Chronic Rhinosinusitis (CRS)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Health-Related Quality of Life (HRQoL) in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from NAVIGATE II

EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps

Letter to the Editor: Incorrect conclusions regarding deposition of conventional mometasone furoate (MF) nasal spray

Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device

Suchergebnisse filtern